8-KEarnings & ResultsLeadership ChangesRegulation FD+1

HCA Healthcare, Inc. 8-K Report, Financial Results (Apr 27, 2009)

Filed April 27, 2009For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on April 27, 2009, to disclose key corporate governance changes and announce its first-quarter 2009 financial results. The report details the resignation of George A. Bitar from the Board of Directors and the immediate appointment of James D. Forbes to fill the vacancy. Mr. Forbes brings significant experience in investment banking, particularly within the healthcare sector, and his appointment is linked to the designation rights of Merrill Lynch Global Private Equity. The most critical piece of information for investors in this filing is the accompanying press release (Exhibit 99.1), which provides HCA's financial performance for the first quarter ended March 31, 2009. While the 8-K itself does not contain the detailed financial figures, it directs investors to this press release for operational and financial condition updates. Investors should review Exhibit 99.1 to understand HCA's recent performance, profitability, and any forward-looking statements or guidance provided by the company.

Key Highlights

  • 1George A. Bitar resigned from HCA's Board of Directors, effective April 22, 2009.
  • 2James D. Forbes was appointed to HCA's Board of Directors, effective April 22, 2009, filling the vacancy left by Mr. Bitar.
  • 3Mr. Forbes' appointment is tied to Merrill Lynch Global Private Equity's right to designate directors, given his background with Merrill Lynch and Bank of America.
  • 4Mr. Forbes will serve on the Compensation Committee of the Board.
  • 5The filing includes a Regulation FD Disclosure, announcing the issuance of a press release on April 27, 2009, detailing first-quarter 2009 results.
  • 6Exhibit 99.1 contains the press release announcing HCA's financial results for the first quarter ended March 31, 2009.
  • 7The 8-K references HCA's 2008 Form 10-K for information regarding relationships with Merrill Lynch Global Private Equity.

Frequently Asked Questions

This 8-K filing announces that HCA issued a press release on April 27, 2009, containing its first-quarter 2009 financial results. The actual detailed financial figures are not included within the text of the 8-K itself but are available in Exhibit 99.1, which is the press release. Investors should refer to Exhibit 99.1 for specific performance data.

The 8-K filing states that George A. Bitar notified the Board of Directors of his intention to resign, effective immediately on April 22, 2009. The filing does not provide a specific reason for his resignation.

James D. Forbes was appointed to HCA's Board of Directors on April 22, 2009. He has a strong background in investment banking, most recently serving as Head of Bank of America’s Global Principal Investments Division. Prior to that, he held senior roles at Merrill Lynch, including Global Head of Healthcare Investment Banking, and also worked at CS First Boston. His appointment fills a vacancy and is linked to the rights of Merrill Lynch Global Private Equity.

Mr. Forbes' appointment to the Compensation Committee is significant as this committee typically oversees executive compensation, incentive plans, and other compensation-related matters. His extensive experience in finance and investment banking may bring a valuable perspective to these decisions, particularly in alignment with shareholder interests.